Whole-body magnetic resonance imaging (WB-MRI) in oncology: recommendations and key uses

On behalf of the Italian Working Group on Magnetic Resonance

Research output: Contribution to journalReview articlepeer-review


The past decade has witnessed a growing role and increasing use of whole-body magnetic resonance imaging (WB-MRI). Driving these successes are developments in both hardware and software that have reduced overall examination times and significantly improved MR imaging quality. In addition, radiologists and clinicians have continued to find promising new applications of this innovative imaging technique that brings together morphologic and functional characterization of tissues. In oncology, the role of WB-MRI has expanded to the point of being recommended in international guidelines for the assessment of several cancer histotypes (multiple myeloma, melanoma, prostate cancer) and cancer-prone syndromes (Li–Fraumeni and hereditary paraganglioma–pheochromocytoma syndromes). The literature shows growing use of WB-MRI for the staging and follow-up of other cancer histotypes and cancer-related syndromes (including breast cancer, lymphoma, neurofibromatosis, and von Hippel–Lindau syndromes). The main aim of this review is to examine the current scientific evidence for the use of WB-MRI in oncology.

Original languageEnglish
Pages (from-to)218-233
Number of pages16
JournalRadiologia Medica
Issue number3
Publication statusPublished - Mar 13 2019


  • Cancer screening
  • Cancer-related syndromes
  • Diffusion-weighted imaging
  • Magnetic resonance imaging
  • Oncology
  • Whole-body MRI

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging


Dive into the research topics of 'Whole-body magnetic resonance imaging (WB-MRI) in oncology: recommendations and key uses'. Together they form a unique fingerprint.

Cite this